Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy Biomarker Collection for Metastatic NSCLC to Inform Adaptive Personalized Models Targeting Resistance (IMMUNO-BIOMAP)

NCT07288034 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT07288034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07288034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy Biomarker Collection for Metastatic NSCLC to Inform Adaptive Personalized Models Targeting Resistance (IMMUNO-BIOMAP)
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
April 8, 2026
Completion date
October 8, 2028
Enrollment
535 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

lung non-small cell carcinoma, stage iiib lung cancer ajcc v8, stage iv lung cancer ajcc v8